Titlebook: Coronary Artery Disease: Therapeutics and Drug Discovery; Miao Wang Book 2020 Springer Nature Singapore Pte Ltd. 2020 coronary artery dise

只看該作者 · 發(fā)表于 2025-3-27 02:15:04

978-981-15-2519-3Springer Nature Singapore Pte Ltd. 2020

只看該作者 · 發(fā)表于 2025-3-27 07:03:25

Miao WangProviding a cutting-edge understanding of the mechanisms of coronary artery disease (CAD).Highlighting the drug pharmacology and therapeutic challenges to treat CAD.Emphasizing the development for CAD

只看該作者 · 發(fā)表于 2025-3-27 10:36:29

只看該作者 · 發(fā)表于 2025-3-27 16:39:32

只看該作者 · 發(fā)表于 2025-3-27 19:30:10

Welcome Address by the Conference Chairmanis discussed, which plays an important role in CAD risk control, including forming healthy dietary pattern, maintaining proper body weight, physical exercise, smoking cessation, and so on. Part 2 elaborated on revascularization strategies and medical treatments in patients presenting with acute coro

只看該作者 · 發(fā)表于 2025-3-28 01:31:17

只看該作者 · 發(fā)表于 2025-3-28 05:01:51

只看該作者 · 發(fā)表于 2025-3-28 08:42:22

Malnutrition in Captive Birds of Preyr atherosclerosis and CAD, which results in cardiac ischemic injury and myocardial infarction. Lipid-modifying drugs can effectively improve lipid abnormalities including reducing low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) or increasing high-density lipoprotein cholesterol (H

只看該作者 · 發(fā)表于 2025-3-28 13:33:56

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 11:20
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved